Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Inventory Average (2017 - 2025)

Historic Inventory Average for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $43.4 million.

  • Ptc Therapeutics' Inventory Average rose 2852.27% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.4 million, marking a year-over-year increase of 2852.27%. This contributed to the annual value of $26.9 million for FY2024, which is 264.58% up from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Inventory Average is $43.4 million, which was up 2852.27% from $27.9 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Inventory Average ranged from a high of $43.4 million in Q3 2025 and a low of $14.9 million during Q3 2022
  • In the last 5 years, Ptc Therapeutics' Inventory Average had a median value of $24.2 million in 2023 and averaged $24.6 million.
  • Per our database at Business Quant, Ptc Therapeutics' Inventory Average skyrocketed by 12729.41% in 2023 and then plummeted by 2600.15% in 2025.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Inventory Average stood at $15.7 million in 2021, then grew by 16.37% to $18.3 million in 2022, then skyrocketed by 81.13% to $33.2 million in 2023, then fell by 11.25% to $29.4 million in 2024, then skyrocketed by 47.37% to $43.4 million in 2025.
  • Its last three reported values are $43.4 million in Q3 2025, $27.9 million for Q2 2025, and $22.4 million during Q1 2025.